Thyritope Biosciences Garners $10,000,000 Series A Financing

  • Feed Type
  • Date
    9/23/2014
  • Company Name
    Thyritope Biosciences
  • Mailing Address
    Undisclosed San Diego, CA 92037 USA
  • Company Description
    Thyritope Biosciences is developing therapeutics that target thyroid stimulating auto-antibodies, which are the causative drivers of Graves’ hyperthyroidism and Graves’ orbitopathy. Graves’ disease is an autoimmune disorder caused by antibodies that over-stimulate the thyroid, causing excessive thyroid hormone production.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
  • Venture Investor